Thomas Mueller

Architecture and properties of anisotropic polymer composite scaffolds for bone tissue engineering

L. Mathieu, Thomas Mueller, P.‐E. Bourban et al. · Biomaterials · 2005 · 349 citations · Full text

Materials Science, Tissue Engineering, Regenerative Medicine +10

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Ulrich Germing, Barbara Hildebrandt, Michael Pfeilstöcker et al. · Leukemia · 2005 · 161 citations

Risk Assessment, Prognostic Assessment, Prognostic Biomarkers +9

Tumor Accumulation of NIR Fluorescent PEG–PLA Nanoparticles: Impact of Particle Size and Human Xenograft Tumor Model

Andreas Schädlich, Henrike Caysa, Thomas Mueller et al. · ACS Nano · 2011 · 157 citations

Nanoparticles, Nanomedicine, Engineering +12

Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.

Thomas Mueller, Wieland Voigt, Heike Simon et al. · PubMed · 2003 · 131 citations

Cisplatin Resistance, Tumor Biology, Caspase-9 Induces +13

Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics

David A. Katz, R. A. Carr, David R. Grimm et al. · Clinical Pharmacology & Therapeutics · 2006 · 98 citations